Skip to content

ALEX ENEMAN

Active
Private limited companyfounded 200224 yrs activeBeernemstraat 31, 8750 Wingene, BelgiumKBO/BCE: BE 0476.551.003
Summary

ALEX ENEMAN has been active since 2002 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €632,757 and a net result of €59,730. Equity is growing by ~17.4% per year across the filed fiscal years. Its solvency ranks better than 94% of 13458 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).

Risk analysisWatch ReportCompare
ALEX ENEMANActiveChecked score 98/100
Risk analysis ReportCompare

Overview

Activity
Wholesale of pharmaceutical and medical goods
NACE 46460NACE 51460NACE 85130
1 site
Size
€667,460total assets 2025
Staff
1 FTE
Equity
€632,757
Profit
€59,730
Turnover not published (abridged schema)
Financial health
98 Excellent Checked score 2025
Bankruptcy chance 12 m
< 0.1%
Structure
Accounts 160 d early0 of 1 deed read
Why 98+ Liquidity: current ratio 18.24, cash €617,818+ Equity €632,757 (94.8% of total assets)+ Founded in 2002+ Size: total assets €667,460Show the evidence

Checked score

Score 2025
98 / 100
Excellent
Probability in this band: under 0.55%
Better than 81% of its sector peers (NACE 46, micro)
Performance against the sector, not lower risk
Every signal that weighs is under Signals.
Financial strength · tick = 2024
Strong
Solvency 100=
equity 94.8% of total assets
Liquidity 100+3
short-term debt 5.2% · cash 92.6%
Profitability 80-9
return on assets 8.9%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.4% (26,788 companies)
Last 24 months 11-2024: < 0.1%lowest value 12-2024: < 0.1%● 0.0% vs 11-2024lowest value 01-2025: < 0.1%▲ +25.9% vs 12-2024highest value 02-2025: < 0.1%● 0.0% vs 01-2025highest value 03-2025: < 0.1%● 0.0% vs 02-2025highest value 04-2025: < 0.1%● 0.0% vs 03-2025highest value 05-2025: < 0.1%● 0.0% vs 04-2025highest value 06-2025: < 0.1%● 0.0% vs 05-2025highest value 07-2025: < 0.1%● 0.0% vs 06-2025highest value 08-2025: < 0.1%● 0.0% vs 07-2025highest value 09-2025: < 0.1%● 0.0% vs 08-2025highest value 10-2025: < 0.1%▼ -2.9% vs 09-2025 11-2025: < 0.1%● 0.0% vs 10-2025 12-2025: < 0.1%▼ -15.2% vs 11-2025 01-2026: < 0.1%● 0.0% vs 12-2025 02-2026: < 0.1%● 0.0% vs 01-2026 03-2026: < 0.1%● 0.0% vs 02-2026 04-2026: < 0.1%● 0.0% vs 03-2026 05-2026: < 0.1%● 0.0% vs 04-2026 06-2026: < 0.1%● 0.0% vs 05-2026 07-2026: < 0.1%● 0.0% vs 06-2026 08-2026: < 0.1%● 0.0% vs 07-2026 09-2026: < 0.1%● 0.0% vs 08-2026 10-2026: < 0.1%▼ -3.6% vs 09-2026lowest value
  • Liquidity: current ratio 18.24, cash €617,818 lowers the probability
  • Equity €632,757 (94.8% of total assets) lowers the probability
  • Founded in 2002 lowers the probability for this profile
  • Size: total assets €667,460 lowers the probability for this profile
Credit up to €60,000 at 30 days acceptable
Liquidity ample (current ratio 18.24 against 16.63 in 2024; short-term debt: 5.2% and cash: 92.6% of total assets), and 5.2% of the assets are financed with debt.
How it is calculated

The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 46, micro). Better than this share of them on solvency 90%, liquidity 98%, profitability 72%, growth against the median 64%. That is performance, not lower risk; the band itself always comes from the probability.

Bankruptcy probability: model pd-v3.202610021621, computed on 03-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.

Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Liquidity: current ratio 18.24, cash €617,818
In the bankruptcy model this factor lowers the probability.
NBB · annual accounts
lowers risk · Equity €632,757 (94.8% of total assets)
In the bankruptcy model this factor lowers the probability.
NBB · annual accounts
lowers risk · Founded in 2002
In the bankruptcy model this factor lowers the probability for this profile.
KBO
lowers risk · Size: total assets €667,460
In the bankruptcy model this factor lowers the probability for this profile.
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 21-11-2025, 160 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
160 d early
2024
142 d early
2023
106 d early
2022
83 d early
2021
117 d early
2020
95 d early
2019
34 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 105 days before the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 39% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-09-2026 and is due by 30-04-2027. Nothing is late today. Usually files around 3 January (4 of the last 5 filed years within 34 days of that day).
Companies Code · seven months
Position in the running window
30-09-2026 close04-10-2026 today30-04-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · micro…
  2. Annual accounts filedfiscal year 2024 · micro…
  3. Highest result since 2019net €97,140 ▲7.1%

Key points

  • Positive: Among the best 5% on equitysector median €57,293 · 13,493 companies €632,757 View
  • Positive: Always filed on timeaccounts within the deadline every year 8 years View
  • Positive: 7 profitable years in a rowprofit 2025: €59,730 7 years View

By topic

Financials

Fiscal year
2025
Total assets
€667,460
Profit
€59,730
Solvency
94.8%
Total assets▲ 9.4%
Net result
20192025
Go to Financials

Timeline

Events
12
Since
2017
Next accounts
by 30-04-2027
  1. 21-11-2025Annual accounts filed
  2. 09-12-2024Annual accounts filed
  3. 30-09-2024Highest result since 2019
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Founded
03-01-2002
Year ends
30-09
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure